Other languages Johnson & Johnson Swiss Exchange

Equities

JNJ

US4781601046

Market Closed - Swiss Exchange Other stock markets 16:36:39 01/03/2023 GMT			5-day change	1st Jan Change
500 ^CHF	+194.12%		-.--%	-.--%

05-28	Sector Update: Health Care Stocks Fall Late Afternoon	MT
05-28	Sector Update: Health Care Stocks Retreat Tuesday Afternoon	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Fall Late Afternoon	05-28
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	05-28
Sector Update: Health Care	05-28
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	05-28
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	05-28
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	05-28
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	05-28
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	05-28
J&J : rachat d'une biotech suisse dans l'eczéma	05-28
J&J acquires rights to skin disorder drug for $1.25 bln	05-28
J&J : va présenter ses avancées lors de l'ASCO et de l'EHA	05-24
Víctimas de cáncer demandan a Johnson & Johnson por quiebras "fraudulentas"	05-22
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	05-22
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	05-22
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American	05-22
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	05-22
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship	05-21
J&J : essai positif pour Tremfya dans la colite ulcéreuse	05-21
Valneva Names New Chief Scientific Officer	05-21
Valneva nomme Hanneke Schuitemaker directrice scientifique et membre du directoire	05-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm